Skip to main content

Legend Biotech Corp

LEGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001801198

In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q1 2023 vs. Q4 2022

How the institutions holding Legend Biotech Corp changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of LEGN: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders170160−10
Shares64.0M68.0M+4.09M (+6.4%)
Value$3.18B$3.28B+$104.3M (+3.3%)

New holders (12)

Institutions that held Legend Biotech Corp at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to LEGN in Q1 2023
InstitutionSharesValue% of portfolio
Iron Triangle Partners LP500,000$24.1M3.48%
PFM Health Sciences, LP472,161$22.8M1.05%
Ardsley Advisory Partners LP180,000$8.68M1.91%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main107,526$5.18M0.01%
Alberta Investment Management Corp12,100$583.5K0.01%
Indus Capital Partners, LLC10,064$485.3K0.74%
E. Ohman J:or Asset Management AB10,000$482.2K0.02%
Teacher Retirement System of Texas7,165$345.0K0.00%
Jane Street Group, LLC6,775$326.7K0.00%
Artia Global Partners LP5,000$241.1K0.10%
Seven Eight Capital, LP4,463$215.2K0.04%
Twin Tree Management, LP344$16.6K0.00%

Sold out (22)

Institutions that held Legend Biotech Corp at the end of Q4 2022 and filed for Q1 2023 without it.